ability to stimulate the expression of genes encoding for diverse growth factors (e.g. 16α-OH-estrone) (2,3,6); and 2 To whom correspondence should be addressed (ii) DNA modifications and formation of adducts derived 3 NCI summer student from Clark Atlanta University School of Biology, from activated metabolites (catechol estrogens) and free Atlanta, GA 30314, USA radicals formed during estrogen metabolism (hydroquinones The metabolic activation of estrone (E1), a potent estrogen or quinones) (7-10). Administration of antiestrogens and was investigated using recombinant human cytochrome modulators or inhibitors of estrogen metabolism has apparently P450 enzymes, 1A2, 2B6, 2C8, 2C9, 2C9 R144C , 2E1, 3A4, resulted in prevention of tumors in some cases (11-13). 3A5 and liver microsomes from 14 human organ donors.
(ii) DNA modifications and formation of adducts derived 3 NCI summer student from Clark Atlanta University School of Biology, from activated metabolites (catechol estrogens) and free Atlanta, GA 30314, USA radicals formed during estrogen metabolism (hydroquinones The metabolic activation of estrone (E1), a potent estrogen or quinones) (7-10). Administration of antiestrogens and was investigated using recombinant human cytochrome modulators or inhibitors of estrogen metabolism has apparently P450 enzymes, 1A2, 2B6, 2C8, 2C9, 2C9 R144C , 2E1, 3A4, resulted in prevention of tumors in some cases (11) (12) (13) .
3A5 and liver microsomes from 14 human organ donors.
Cytochromes P450 (P450*) play a central role in the At least five products of E1 were detected and quantitated oxidative metabolism of a large number of endogenous and by HPLC and gas chromatography-mass spectrometry exogenous compounds (14) (15) (16) (17) .
P450 enzymes are particularly (GC-MS). Among these metabolites, 16α-OH-E1, 2-OH-E1
prominent in hepatic tissue, where they catalyze the NADPHand 4-OH-E1, which are believed to be associated with dependent monooxygenation of structurally diverse lipophilic estrogen carcinogenesis in animals, were definitively identisubstrates to yield more polar derivatives. The biosynthesis of fied. Of all P450s examined, 1A2 and 3A4 exhibited the estrogens from androgens is mediated by the action of a highest activities with turnovers of 3.4 and 2.5 nmol/min/ specific P450 called aromatase (CYP 19) . Once formed, nmol P450 for the total metabolism of E1, respectively, estrogens undergo extensive metabolism via the action of while 3A5, 2C9 and 2C9 R144C showed moderate activities.
various P450s. Oxidation of estrogens can lead to deactivation 2B6, 2E1 and 2C8 did not produce any significant amount and elimination, or alternatively, may result in production of of products. 1A2 formed almost exclusively the 2-OH- E1 metabolites that have altered hormonal properties (18) , or give at a rate of 3.3 nmol/min/nmol but 3A4 preferentially rise to the formation of reactive derivatives that are responsible formed the metabolite X1 (an unknown hydroxylation for the chemotherapeutic, mutagenic or carcinogenic properties product) and 16α-OH-E1. Kinetic characterization showed of the parent compound (19) (20) (21) . that the K m values of 1A2, 3A4 and 3A5 were 14, 95 and Endogenous and exogenous estrogens can undergo extensive 64 µM and V max were 5.43, 0.68 and 0.35 min -1 , respectively.
hydroxylation primarily at C 2 , C 4 , C 6 , C 15 or C 16 position by All human liver microsomes were capable of metabolizing specific rodent P450s (22-24). Oxygenated metabolites have estrone and a 4-fold variation was seen between individuals.
different biological activities such as 16α-, 2-or 4-hydroxyl The relative amount of metabolites formed was generally estrogens (22). Previous studies have shown that liver and 2-OH-E1 Ͼ metabolite X1 Ͼ 4-OH-E1 Ͼ 16α-OH-E1 Ͼ kidney microsomes of adult hamsters and rats extensively metabolite X2. 3A4/5 enzyme complex was assessed by converted estrone (E1) to the major metabolites, 15β-, 7α-, inhibitory monoclonal antibody specific for 3A4/5 to con-6α-, 6β-, 4-and 2-OH-E1, and minor metabolite 16α-OHtribute 60-88% to the formation of individual metabolites E1 (25) (26) (27) . 2-OH-E1 accounted for 26% and 9% of total in human liver except for 2-OH-E1 (3%). The formation metabolites formed in kidney and liver microsomes of hamster, of 2-OH-E1 and 16α-OH-E1 by 14 human liver microsomes respectively. Using hepatic microsomes, the rate of was significantly correlated with caffeine 3-demethylation supported by 1A2 (r 2 ϭ 0.87) and with testosterone 6β-2-hydroxylation of estrone was comparable to that found hydroxylation by 3A4 (r 2 ϭ 0.66), respectively. Thus the using estradiol as substrate, whereas 4-hydroylation of estrone metabolic patterns exhibited by human liver are likely due was double that of estradiol. Using renal microsomes, the rates to the combined activities of the P450 1A2 and 3A4 of 2-and 4-hydroxylation of estrone were 10-to 20-fold higher enzymes.
than those with estradiol as substrate. The ratio of 2-: 4-: 16α-hydroxylation of estrone in hamster liver microsomes was about 7 : 4 : 1 (27) .
Introduction
Induction of P450 enzymes has been studied with respect to those P450s effecting oxidative metabolism of estrogens. Estrogens have been implicated in the etiology of cancers in Phenobarbital has been shown to induce 2-hydroxylation (28 what P450 isoforms are responsible for the metabolic activation
Reactions were followed for 20 min and terminated with 6 volumes of methylene chloride. 7-(2-Hydroxypropyl)-1,3-dimethylxanthine, chlorpropof estrone in human.
amide, 6β-OH-progesterone and benzo[a]pyrene-9,10-dihydrodiol were used, respectively, as internal standards for quantitation of metabolites formed in
Materials and methods
the metabolism of caffeine (43), tolbutamide (44), testosterone (45) and chlorzoxazone (46). Extracts of products were dissolved in a mixture of Materials methanol and water and analyzed immediately by reversed-phase HPLC (see Estrone, 17β-estradiol, 2-OH-E1, 4-OH-E1, 16β-OH-E2, 11β-OH-E1, 16α-below). The metabolites formed were identified by comparing their retention OH-E1, 6β-OH-E2, 6β-OH-testosterone and testosterone were purchased times with authentic standards. ternary solvent delivery system, and a multiple wavelength detector. Metabolvidual P450s were prepared as previously described (32) . Inhibitory monoites formed in the metabolism of estrone were separated on Ultrasphere ODS clonal antibody (MAb 3-29-9) specific for 3A4/5 was characterized in a column (5 µm, 4.6 mm ϫ 25 cm, Beckman Instruments, Inc., Fullerton, CA) previous report (33) . Figure 1 . HPLC chromatographic areas of all metabolites at 280 nm on the donors was provided with automobile accidents (eight cases), coronary UV absorption were normalized to that of B[a]P cis-4,5-diol as an internal artery disease (one case), respiratory failure (two cases), breast cancer (one standard for quantitation of metabolites. Rates for metabolite formation were case) and hepatic adenoma (one case). These donors are non-smokers and determined as nmol of product formed/min, nmol of P450. Caffeine and its non-alcoholics. All liver specimens were frozen within 6 h post surgery or metabolites were separated on an Ultrasphere ODS column eluted with a autopsy. Microsomes were prepared as described previously (34). Microsomal mixture of acetonitrile:tetrahydrofuran:water (4:1:95, v/v/v) for 10 min and preparations, containing 0.4-0.8 nmol P450/mg protein were stored at -80°C then 20-min linear gradient to 99% acetonitrile in tetrahydrofuran at a flow until further use.
rate of 1 ml/min. The retention times of paraxanthine (3-demethylation Expression of P450s in HepG2 cells product), caffeine and internal standard were 8.7, 15.3 and 20 min, respectively. Tolbutamide and its metabolite were isolated on a 20/20 ODS column (4.6 mm The construction and characterization of recombinant vaccinia viruses coni.d. ϫ 200 mm, TLC, Springfield, VA), eluted with 13-min linear gradient taining P450s 1A2 (35), 2B6 (36), 2C8 (37), 2C9 (37), 2C9 R144C (38), 2E1 from 10% to 70% acetonitrile in water containing 0.5% acetic acid at a flow (39), 3A4 (40), and 3A5 (40) were as previously reported. The human rate of 1 ml/min. Retention times of hydroxy tolbutamide, internal standard TK -143 lymphoblastoid cell line was used for preparation of stocks of and tolbutamide were 9.3, 12.2 and 12.9 min, respectively. Testosterone recombinant vaccinia viruses. Hepatoma G2 cells (HepG2) were used for metabolites were analyzed according to the previous report (45) . Chlorzoxazone enzyme expression. They were grown to confluence on 175 cm 2 plastic flasks, and its 6-hydroxy metabolite were separated on a 20/20 column, eluted with infected with the recombinant vaccinia virus. The vaccinia virus is a lytic 20-min linear gradient of 10% acetonitrile in water containing 0.5% H 3 PO 4 virus that kills the cells. Thus the cells were harvested 24 h after infection.
(pH ϭ 3) to 80% acetonitrile at a flow rate of 1 ml/min. Retention times of For measurement of their P450 contents by Fe 2ϩ -CO versus Fe 2ϩ difference the 6-hydroxy metabolite, chlorzoxazone and internal standard were 9.0, 13.2 spectroscopy (41) and for metabolism studies, the cells were lysed by and 14.6 min, respectively. sonication and centrifuged at 500 000 g for 12 min. The pellet containing membrane proteins was then resuspended with 50 mM potassium phosphate GC-MS buffer (KPi). The protein concentration was determined by using a bicin-HPLC fractions used for GC-MS analysis were evaporated to dryness and choninic acid procedure according to the manufacturer's directions (Pierce residues were dissolved in 50 µl of methylene chloride. Derivatizing reagent Chemical Co., Rockford, IL). The membrane protein of HepG2 cells infected N,O-bis(trimethylsilyl)acetamide (BSA, 5 µl) was added and incubated overwith wild-type vaccinia virus was used as control for metabolic experiments.
night at 50°C. GC-MS analysis was performed on a Hewlett-Packard 5890
Metabolism of estrone with P450s
instrument with a 5971 mass selective detector. A Heliflex (Deerfied, IL) AT-1 silica capillary column (30 m long, 0.25 mm i.d., 1 mm thick) was used. One milliliter incubation mixture contained the membrane proteins adjusted from 20 to 100 pmol P450s expressed from HepG2 cells or of human liver
The column was set at a temperature range of 100-300°C (30°C/min from 100 to 150°C and then 15°C/min from 150 to 300°C) and maintained at microsomes, 50 mM KPi buffer (pH ϭ 7.4) and 200 µM estrone. The mixture was preincubated for 2 min at 37°C in a shaking water bath, and the reaction 300°C for 20 min. Electron impact mass spectra were taken at an electron energy of 70 eV and mass range was scanned from 50 to 550 m/e. Two was initiated by addition of 1 mM NADPH and incubated for 20 min. For MAb inhibition study, MAb 3-29-9 (IgM) was used as previously reported microliters of each sample were injected into the column via an autosampler human subjects. Incubation and separation conditions were described in human liver microsomal samples and their % standard deviations are Materials and methods. The rates of metabolite formation are expressed as ഛ21%.
nmol of metabolite formed/min, nmol of P450 protein.
Results

metabolism of estrone were characterized as hydroxylated P450 expression
products by their mass spectra (derivatized with BSA, m/z ϭ 430) and were further confirmed by the inhibition study in Vaccinia virus has been used to express a number of rat, mouse and human P450s (32) . The virus containing a P450 cDNA which inhibitory MAb 3-29-9 inhibited the 3A4-and 3A5-catalyzed metabolism of estrone by 87% and 66%, respectively can be used to infect HepG2 cells to produce active P450. The levels of expression ranging from 15 to 50 pmol/mg (Table I) . However, the molecular structures of metabolites X1 and X2 remain to be determined. membrane protein can be obtained for different P450s. HepG2 cells are used as hosts for expression because they have ample Specificity of individual P450s endoplasmic reticulum, oxidoreductase, and cytochrome b5
Recombinant vaccinia virus vectors encoding eight individual (47). When the recombinant vaccinia viruses are used to infect P450 cDNAs were used to express P450 proteins. The rates HepG2 cells, maximal P450 catalytic activities obtained are for five metabolites (X1, X2, 16α-OH-, 2-OH-and 4-OH-E1) usually equal to or greater than the optimized reconstituted were determined with reference to an internal standard and systems. For kinetic parameters produced by a P450 form in specific activities for various cDNA-expressed P450s were an expression system, K m and V max values can be reproduced compared as described in Table I . Of all cDNA-expressed as observed in liver microsomes (48) . Since the P450 contents P450s, 1A2 exhibited the highest activity in total metabolism can be quantitated and only NADPH is required for activity of estrone (3.41 nmol/min/nmol P450), followed by 3A4 determination, the vaccinia virus expression system is particu-(2.54), 3A5 (0.77), 2C9 R144C (0.58), 2C9 (0.32), 2C8 (0.23), larly useful for carcinogen and drug metabolism studies. 2E1 (0.07), and finally 2B6 (0.05). Wild-type control cells Separation and identification of estrone metabolites exhibited very low background metabolism, indicating that the observed activity is due to the expressed P450. Thus, 1A2 and The representative HPLC profiles for P450 3A4-, 1A2-and human liver microsomal-catalyzed metabolism are shown in 3A4 were shown to be primary enzymes for the metabolism of estrone and displayed 5-fold greater activity than any of Figure 1 . At least five major chromatographic peaks were detected and identified. These metabolites were fractionated the other P450s employed in this study. The individual P450s showed characteristic regiospecificity in the metabolite profiles from pooled HPLC separations and applied to GC-MS. Metabolites 16α-OH-E1, 2-OH-E1 and 4-OH-E1 were identified produced. As seen in Table I , 1A2 preferentially catalyzed the formation of 2-OH-E1 at a rate of 3.3 nmol/min/nmol P450 by comparison of retention times on HPLC and mass spectra with that of available authentic standards as seen in Figures 1 and had 14-fold higher activity than any of other P450s. P450 3A4 exhibited the regiospecificity, preferentially forming and 2. Metabolites X1 and X2, major peaks of 3A4-catalyzed Fig. 4 . Correlations between estrone metabolism and the activities of individual P450s supported by 1A2 (caffeine 3-demethylation), 3A4 (testosterone 6β-hydroxylation), 2C8/9 (tolbutamide hydroxylation) and 2E1 (chlorzoxazone 6-hydroxylation) were assayed with human liver microsomes. The r 2 is the squared correlation coefficient and the statistical significance of the r 2 is tested by t test and r values are shown in this figure. The specific activity was expressed as nmol of product formed/min/nmol of P450 enzyme. metabolism, were monitored to determine kinetic parameters at a range of concentrations of estrone (6-100 µM). Table II showed kinetic parameters (K m and V max ) for three active P450 enzymes. Kinetic values indicated that 1A2 had a higher apparent affinity for substrate (4.5-to 6.6-fold smaller K m than 3A enzymes) and a V max of 8-to 15-fold higher than 3A enzymes.
Human liver microsomal metabolism
Fourteen human liver microsomal samples were investigated for their ability to metabolize estrone as shown in Figure 3 . Although human liver microsomes exhibited variable specific activity (~4-fold difference in total metabolism between individuals), similar metabolic patterns were observed. 2-OH-E1 was a predominant metabolite produced at rates ranging from 0.28 to 0.75 (nmol/min/nmol P450), followed by metabolite X1 (0.04-0.23), 4-OH-E1 (0.05-0.1), 16α-OH-E1 (0.02-0.08) and metabolite X2 (0.01-0.04).
3A4 MAb inhibition
MAb 3-29-9 was prepared to human P450 3A4 from mice immunized with baculovirus-expressed human P450 3A4 (33) . MAb 3-29-9 was a powerful inhibitor of the enzymatic activity of P450 3A4/5 and did not exhibit the cross-immunoinhibition 1A1, 1A2, 2B6, 2C8, 2C9, 2D6 and 2E1 (data not shown), respectively. To assess quantitatively the contribution of 3A4 primary metabolite X1 Ͼ 16α-OH-E1 Ͼ catechols. 3A5 had to the metabolism of estrone in 14 human liver samples, an a metabolic pattern similar to, but specific activity less than inhibitory MAb 3-29-9 specific to 3A4 and partially to 3A5 3A4. 2C9 and 2C9 R144C had moderate activities in the formation was used as a probe (33) . The inhibitory activities of MAb at of metabolite X1 and 2-OH-E1. 2B6, 2E1 and 2C8 did not various concentrations of IgM in ascites were observed on the produce any significant amount of products. metabolism of estrone by 3A4 and 3A5. Thus, 60 nM IgM of
Enzyme kinetics
MAb was chosen to generate the highest inhibitory effects on total metabolism of estrone which were given by 87% for 3A4 The values of K m and V max of major P450 enzymes 1A2, 3A4 and 3A5 were determined to assess the kinetic characteristics and 66% for 3A5 (Table I) . MAb inhibited the formation of metabolites X1, X2, 16α-OH-E1 and 4-OH-E1 generated from of individual P450s. 2-OH-E1, a predominant product of 1A2 and 16α-OH-E1, a principal product of 3A4/5-mediated 14 human liver microsomes by 74%, 71%, 88% and 60%, respectively. However, MAb did not inhibit 2-OH-E1 formation regioselective in generation of hydroxyl products at specific sites. 1A2 is the most active enzyme, and almost exclusively (only 3% inhibition) which suggests that 2-OH-E1 production is a function of P450(s) other than 3A4/5. The 58% inhibition forms 2-OH-E1. The K m of 1A2 is 4.5-to 6.6-fold smaller than that observed for 3A enzymes (Table II) , suggesting that in total metabolism of estrone demonstrates that the human P450 3A4/5 complex contributes not less than 58% to the substrate has the highest apparent affinity for 1A2. Metabolic profiles of 14 human liver microsomes indicate metabolism of estrone in human liver.
that 2-hydroxylation predominates. Comparison of specificities Correlation studies of individual cDNA-expressed P450s and correlation studies Regarding the formation of the major identifiable metabolites confirm that 1A2 is the main P450 involved in 2-hydroxylation (2-OH-E1 and 16α-OH-E1) produced by human liver microin human liver. The specific activity of liver microsomes for somes, significant correlations were observed between estrone the 2-hydroxylation of estrone was 7.4-fold less than that 2-hydroxylation and the caffeine-3-demethylation (1A2, r 2 ϭ observed from cDNA-expressed 1A2, indicating that the 0.87) and between estrone 16α-hydroxylation and testosterone amount of 1A2 expressed in human liver may account for 6β-hydroxylation (3A4, r 2 ϭ 0.66) (Figure 4) . Conversely, approximately one seventh or less of total P450s. 3A4/5 poor correlations of 2-OH-E1 formation were observed with MAb inhibition study indicates that 3A4/5 enzyme complex testosterone 6β-hydroxylation (3A4, r 2 ϭ 0.24), chlorzoxazone quantitatively contributes to the formation of metabolites X1, 6-hydroxylation (2E1, r 2 ϭ 0.2) and tolbutamide hydroxylation X2, 16α-OH-E1 and 4-OH-E1 by 74%, 71%, 88% and 60%, (2C8/9, r 2 ϭ 0.11). This suggested a role for 1A2 and 3A4 as respectively as well as to total metabolism of estrone by 58% major catalysts in human liver for the formation of 2-OH-E1 in human liver. Interestingly, the formation of 2-OH-E1 in and 16α-OH-E1, respectively.
human liver was not affected by the presence of MAb 3-29-9, suggesting that 2-OH-E1 production is due to the P450(s) Discussion such as 1A2 other than 3A4/5 enzymes in multiple isoforms contained in human liver. 3A4 is the most active enzyme It has been established that the oxidative metabolism of estrogens involves specific P450 enzymes, and some of the capable of forming primary metabolites X1, 16α-OH-E1 and 4-OH-E1. Although the structure of metabolite X1 is not biological activities exhibited by estrogens such as macromolecule modification and tumorigenicity are believed to definitively identified, a major conversion of E1 to X1 and 16α-OH-E1 probably reflects the inactivation and activation proceed via the metabolic formation of 16α-OH-and catechol estrogens (22,25,49-51). In recent years, evidence has accumupathways of E1 derived from 3A4-catalysis, respectively. A close correlation between the formation of 16α-OH-E1 and lated indicating that 2-and 4-catechol estrogens may regulate hormonal action in the hypothalamus, pituitary, brain and 6β-OH-testosterone in human liver microsomes suggests that 3A4 is responsible for the 16α-hydroxylation. These results are uterus (52-54) and may play a role in the tumorigenic process in which reactive intermediates (semiquinone, quinone or its similar to those found previously for hamster liver microsomal metabolism of estrone by Zhu et al. (27) . In this study, the free radicals) are generated for direct DNA damage or/and DNA adduct formation (55) (56) (57) (58) (59) (60) . Catechols formed are rapidly values of K m and V max for 2-OH-E1 (major) and 16α-OH-E1 (minor) formation, as markers for 1A2 (MC4) and 3A (3A10) methylated at the 2-, 3-or 4-hydroxy position, by catechol O-methyltransferase (COMT) (50). With increased catechol in hamster were 29.8 and 34.4 µM, and 1.5 and 0.3 nmol/min/ mg protein, respectively. Taken together, our findings suggest biosynthesis or deficient COMT, these metabolites are easily oxidized to semiquinones and quinones. Reactive semiquinones that the metabolic profiles exhibited by human liver microsomes are a reflection of the combined activities of 1A2 and and/or quinones could be the ultimate carcinogens of estrone. Metabolite 16α-OH-E1 is a uniquely reactive estrogen, which 3A4 enzymes. The metabolic activation pathways of estrone catalyzed by 1A2 and 3A4 are proposed as shown in Figure  is known to be present in humans at levels comparable to estradiol (61) . The carcinogenicity of estrogens in their target 5. Thus, carcinogenicity of estrone in human may be elicited through a metabolic activation of E1 to catechol and 16α-OHorgans may be mediated by 16α-hydroxylation of the hormone, based on studies reporting covalent linking of 16α-OH-E1 to E1 metabolites, in which 1A2 and 3A4 may play a critical role. proteins, in particular to estrogen receptors (62) .
Although estrone metabolism has not been studied using References individual human P450s and human liver microsomes, the product specificity of the P450 isoforms. were found to be capable of catalyzing estrone and were highly
